Cart
sales@molnova.com
PF-05150122
CAS No. 1235406-03-7
PF-05150122( PF05150122 )
Catalog No. M10944 CAS No. 1235406-03-7
PF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 369 | In Stock |
|
| 5MG | 287 | In Stock |
|
| 10MG | 430 | In Stock |
|
| 25MG | 710 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-05150122
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM.
-
DescriptionPF-05150122 is a potent, state-dependent, subtype selective Nav1.7 inhibitor with IC50 of 21 nM, no significant activity against Nav1.5.Pain Phase 1 Discontinued.
-
In VitroPF-05186462 inhibits human Nav1.7 channels (IC50=21 nM) in HEK293 cells.PF-05186462 exhibits a high plasma protein binding rate.
-
In Vivo——
-
SynonymsPF05150122
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1235406-03-7
-
Formula Weight531.885
-
Molecular FormulaC19H10ClF4N5O3S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5-chloro-2-fluoro-4-(2-(pyridazin-4-yl)-4-(trifluoromethyl)phenoxy)-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Swain NA, et al. J Med Chem. 2017 Aug 24;60(16):7029-7042.
2. Jones HM, et al. Clin Pharmacokinet. 2016 Jul;55(7):875-87.
molnova catalog
related products
-
Oxybuprocaine hydroc...
Oxybuprocaine hydrochloride is a local anesthetic, which is used especially in ophthalmology and otolaryngology.
-
Zoniporide hydrochlo...
Zoniporide hydrochloride is a selective inhibitor of NHE-1 with IC50 of 14 nM which is >150-fold selectivity versus other NHE isoforms. Zoniporide hydrochloride shows an IC50 of 59 nM for NHE-1-dependent swelling of human platelets.
-
Evenamide
Evenamide is a sodium channel blocker.
